Herbal Menopause Therapy a Good Fit for Breast Cancer Patients?October 08, 2008COLUMBIA, Mo. - When it comes to understanding the effectiveness and safety of using herbal therapies with other drugs, much is unknown. Now, a University of Missouri researcher will study how black cohosh - an herbal supplement often used to relieve hot flashes in menopausal women - interacts with tamoxifen, a common drug used to treat breast cancer. As women age and reach menopause, their risk of developing breast cancer increases. Many women who have, or are at risk, for breast cancer take tamoxifen. The drug prevents approximately 50 percent of breast cancers in women who have an increased risk of developing breast cancer. However, when women take tamoxifen, they cannot take hormone replacement therapies to relieve menopausal symptoms. Their options are limited to taking antidepressants that can have complications, enduring uncomfortable menopausal symptoms, or trying the black cohosh. "Hopefully, this study will provide evidence that black cohosh is safe to use for breast cancer patients," said Rachel Ruhlen, a postdoctoral researcher in the MU School of Medicine. "Currently, there is little reliable information guiding women in how they can use foods and botanical supplements to enhance their treatment or improve their quality of life." To study how black cohosh and tamoxifen interact, Ruhlen will use a group of rats prone to breast cancer, known as ACI rats. Previous studies have found that human breast cancer is associated with life-time exposure of estrogen. ACI rats, like humans, develop mammary tumors after exposure to estrogen. In a previous study, Ruhlen found that when ACI rats were treated with the human breast cancer drug tamoxifen, mammary tumor mass was reduced by 89 percent.
"Many animal models of breast cancer differ in important ways from humans with breast cancer," Ruhlen said. "These models are useful in studying how human tumors grow and spread to other parts of the body, but fall short because of the difference in how human tumors begin. However, mammary tumors in ACI rats share several key features with the majority of human breast cancers, particularly in how tumors start. Because the ACI rats develop tumors and can be treated in a way similar to humans, it is a relevant model for human breast cancer." Ruhlen's research on black cohosh and tamoxifen is funded by Susan G. Komen for the Cure. Her paper, "Tamoxifen induces regression of estradiol-induced mammary cancer in ACI.COP-Ept2 rat model," will be published in Breast Cancer Research and Treatment. Ruhlen works with Salman Hyder, a professor of biomedical sciences in the College of Veterinary Medicine and investigator in the Dalton Cardiovascular Research Center. University of Missouri | |||||||||||||||||||||
|
Related Breast Cancer Current Events and Breast Cancer News Articles Hormone therapy associated with reduced colorectal cancer risk The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research. Team finds breast cancer gene linked to disease spread A team of researchers at Princeton University and The Cancer Institute of New Jersey has identified a long-sought gene that is fatefully switched on in 30 to 40 percent of all breast cancer patients, spreading the disease, resisting traditional chemotherapies and eventually leading to death. Dormant cancer cells rely on cellular self-cannibalization to survive A single tumor-suppressing gene is a key to understanding, and perhaps killing, dormant ovarian cancer cells that persist after initial treatment only to reawaken years later, researchers at The University of Texas M. D. Anderson Cancer Center report in the December Journal of Clinical Investigation. How to enhance non-thermal effects of ultrasound In recent years HIFU has been widely used for the treatment of solid tumors, such as liver tumor, bone tumor, and breast cancer. The mechanism for therapeutic actions of HIFU includes thermal effects and non-thermal effects with the latter dominated by cavitational effects. Obesity Increases Lymphedema Risk for Breast Cancer Survivors Throughout the world, 10 million breast cancer survivors have a lifetime risk for developing lymphedema, a chronic condition that involves swelling of the limbs and impacts physical and psychosocial health. Researchers compile 'molecular manual' for 100s of inherited diseases An international research team has compiled the first catalogue of tissue-specific pathologies underlying hundreds of inherited diseases. Modified gene targets cancer cells a thousand times more often than healthy cells Researchers at the University of Rochester have designed a gene that produces a thousand times more protein in cancer cells than in healthy cells. Meta-analyses of global trials finds in favor of aromatase inhibitors Two separate meta-analyses of clinical trials from around the world that tested tamoxifen against aromatase inhibitor drugs in postmenopausal women with early breast cancer have each reached the same conclusion: aromatase inhibitors are more effective in preventing breast cancer from coming back. Interactive gene 'networks' may predict if leukemia is aggressive or slow-growing Rather than testing for individual marker genes or proteins, researchers at the University of California, San Diego (UC San Diego) and the Moores UCSD Cancer Center have evidence that groups, or networks, of interactive genes may be more reliable in determining the likelihood that a form of leukemia is fast-moving or slow-growing. Confusing risk information may lead to poor cancer treatment choices A new study from researchers at the University of Michigan Comprehensive Cancer Center found that a tool commonly used by doctors to estimate the risk of a woman's breast cancer returning after surgery is not very effective at explaining risk to patients. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||